Yi-Wei Huang (Y-W Huang)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Atopic Dermatitis

Chronic Obstructive Pulmonary Disease

Rheumatoid Arthritis Patients

Top Venues

Experimental dermatology

The Kaohsiung journal of medical sciences

American journal of clinical dermatology

Dermatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Chang-Yu Hsieh, Yi-Wei Huang, Yi-Hsuan Huang, Tsen Fang Tsai
Deficiency of interleukin-36 receptor antagonist (DITRA): An analysis of 58 Chinese patients in a tertiary hospital in Taiwan. Experimental dermatology (2023)
Chen-Pu Yeh, Yi-Wei Huang, Tsen-Fang Tsai
Comparison of the relative efficacy of different biologics in different body areas in patients with moderate to severe psoriasis receiving biologics and tofacitinib in phase 3 randomized controlled trials: a 15-year single-center experience. Expert review of clinical pharmacology 15 (7) (2022)
Cho-Hsun Hsieh, Yi-Wei Huang, Tsen Fang Tsai
Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review. Dermatology and therapy 12 (4) (2022)
Yi-Wei Huang, Wei-Hsin Wu
Ethambutol-induced subacute cutaneous lupus erythematosus. The Kaohsiung journal of medical sciences 38 (9) (2022)
Yi-Wei Huang, Tsen Fang Tsai
HLA-Cw1 and Psoriasis. American journal of clinical dermatology 22 (3) (2021)
Yi-Wei Huang, Tsen Fang Tsai
Pharmacological Management of Pediatric Pustular Psoriasis. Paediatric drugs 22 (3) (2020)
Yi-Wei Huang, Tsen-Fang Tsai
A drug safety evaluation of risankizumab for psoriasis. Expert opinion on drug safety 19 (4) (2020)
Yi-Wei Huang, Tsen Fang Tsai
Juvenile-onset pustular psoriasis: case series and literature review. The British journal of dermatology 182 (3) (2019)